InBody is valuable tool for doctors so they can easily understand their overweight patients or patients with risk factors associated with diabetes. InBody technology provides accurate measures for body composition through its four core technologies. That information is then translated into useful outputs such as body fat percentage, total body water, lean body mass and visceral fat area. Visceral fat area having an important contribution to diabetics because of the association between high visceral fat levels and diabetes.
Biometric data is gathered by InBody’s four core technologies:
Multi-frequency Measurements are able to measure extracellular water (ECW) and intracellular water (ICW), providing an accurate and quantitative measure of total body water.
Direct Segmental Measurement
Direct Segmental Measurement divides the body into five separate cylinders and measures the impedance for each segment.
8-Point Tactile System
The 8-Point Tactile System with thumb electrodes offers reliable reproducibility by ensuring that tests are always beginning at the same anatomical starting points.
No need for empirical estimations
These technologies combined eliminate any need for empirical data(assumptions for body composition based on factors like age, gender or ethnicity).
What is Diabetes?
Type 2 Diabetes has been linked to obesity and high levels of visceral fat. Physicians need to understand their patient’s body composition to assess health risks for diseases like diabetes. Understanding body composition can influence the occurrence of diabetes and in some cases, improving body composition can lessen conditions of diabetic conditions.
This study used InBody for visceral fat area (VFA), body fat mass (BFM), and percent body fat (%BF) and found that positive changes in VFA and BFM improved glycemic control and lipid parameters, resulting in improved diabetic state and decreased cardiovascular risk.
Hancu (2016) – Changes in fasting plasma glucose, HbA1c and Triglycerides are related to changes in body composition in patients with type 2 diabetes.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.